MRI of endolymphatic hydrops in patients with intralabyrinthine schwannomas: a case-controlled study using non-enhanced T2-weighted images at 3 T.


Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 03 02 2020
accepted: 03 08 2020
pubmed: 10 8 2020
medline: 21 5 2021
entrez: 10 8 2020
Statut: ppublish

Résumé

Like other vestibular schwannomas developing in the internal auditory canal, intralabyrinthine schwannomas (ILS) may present with similar symptoms as in endolymphatic hydrops. Two different studies have described MR saccular hydrops in ~ 30% of internal auditory canal vestibular schwannomas, but this association has never been studied in ILS before. The aim of this work is to study the prevalence of a saccular dilation in ILS, on a T2-weigthed sequence at 3 T, compared to a control group. All patients presenting with typical ILS between January 2008 and October 2018 were included (n = 28, two patients with bilateral tumors) and compared to a control group (n = 53). All underwent a high-resolution T2-weighted 3D sequence (FIESTA-C). The height and width of the saccule were measured on a coronal plane by two radiologists. The saccule was dilated on the side of the schwannoma in 47% of the cases (p = 0.0006 for the height, p = 0.0487 for the width). Bilateral saccular dilation was observed in 37% of the cases. There was a statistically significant correlation between the presence of a saccular hydrops and balance disorders (p = 0.02) as 50% of the patients with an intralabyrinthine schwannoma who presented with such symptoms had a saccular dilation. Forty-seven percent of ILS are associated with homolateral saccular dilation, which is an MR sign of endolymphatic hydrops (bilateral in 37%) and it appears related to the presence of balance disorders. This opens new therapeutic potentialities with the possible use of anti-vertiginous drugs, which could have a beneficial effect on their clinical symptomatology.

Identifiants

pubmed: 32770410
doi: 10.1007/s00405-020-06271-6
pii: 10.1007/s00405-020-06271-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1821-1827

Références

Tieleman A, Casselman JW, Somers T, Delanote J, Kuhweide R, Ghekiere J, Offeciers EF (2008) Imaging of intralabyrinthine schwannomas: a retrospective study of 52 cases with emphasis on lesion growth. Am J Neuroradiol 29(5):898–905
doi: 10.3174/ajnr.A1026
Kennedy RJ, Shelton C, Salzman KL, Davidson HC, Harnsberger HR (2004) Intralabyrinthine schwannomas: diagnosis, management, and a new classification system. Otol Neurotol 25(2):160–167
doi: 10.1097/00129492-200403000-00014
Dispenza F, De Stefano A, Flanagan S, Romano G, Sanna M (2008) Decision making for solitary vestibular schwannoma and contralateral Meniere’s disease. Audiol Neurotol 13(1):53–57
doi: 10.1159/000108109
Ralli M, Greco A, Altissimi G, Turchetta R, Longo L, Dâ Aguanno V, de Vincentiis M (2017) Vestibular schwannoma and ipsilateral endolymphatic hydrops: an unusual association. Int Tinnitus J 21(2):128
pubmed: 29336131
Kentala E (2000) Vestibular schwannoma mimicking Meniere's disease. Acta Otolaryngol 120(543):17–19
doi: 10.1080/000164800453838
Jerin C, Krause E, Ertl-Wagner B (2015) Endolymphatic hydrops in a patient with a small vestibular schwannoma suggests a peripheral origin of vertigo. Austin J Radiol 2015(6):1033
Nakashima T, Naganawa S, Teranishi M, Tagaya M, Nakata S, Sone M, Nishio N (2010) Endolymphatic hydrops revealed by intravenous gadolinium injection in patients with Ménière's disease. Acta Otolaryngol 130(3):338–343
doi: 10.3109/00016480903143986
Karch-Georges A, Veillon F, Vuong H, Rohmer D, Karol A, Charpiot A, Venkatasamy A (2019) MRI of endolymphatic hydrops in patients with vestibular schwannomas: a case-controlled study using non-enhanced T2-weighted images at 3 Teslas. Eur Archiv Oto-Rhino-Laryngol 276:1–9
doi: 10.1007/s00405-019-05395-8
Simon F, Guichard JP, Kania R, Franc J, Herman P, Hautefort C (2017) Saccular measurements in routine MRI can predict hydrops in Menière’s disease. Eur Arch Otorhinolaryngol 274(12):4113–4120
doi: 10.1007/s00405-017-4756-8
Dubernard X, Somers T, Veros K, Vincent C, Franco-Vidal V, Deguine O, Mondain M (2014) Clinical presentation of intralabyrinthine schwannomas: a multicenter study of 110 cases. Otol Neurotol 35(9):1641–1649
doi: 10.1097/MAO.0000000000000415
Naganawa S, Satake H, Kawamura M, Fukatsu H, Sone M, Nakashima T (2008) Separate visualization of endolymphatic space, perilymphatic space and bone by a single pulse sequence; 3D-inversion recovery imaging utilizing real reconstruction after intratympanic Gd-DTPA administration at 3 Tesla. Eur Radiol 18(5):920–924
doi: 10.1007/s00330-008-0854-8
Gomez MT, Duro DL, Alvarez BB, Garcia-Berrocal JR (2017) Diagnosis of endolymphatic hydrops by means of 3 T magnetic resonance imaging after intratympanic administration of gadolinium. Radiología (English Edition) 59(2):159–165
doi: 10.1016/j.rxeng.2017.02.001
Attyé A, Eliezer M, Boudiaf N, Tropres I, Chechin D, Schmerber S, Krainik A (2017) MRI of endolymphatic hydrops in patients with Meniere’s disease: a case-controlled study with a simplified classification based on saccular morphology. Eur Radiol 27(8):3138–3146
doi: 10.1007/s00330-016-4701-z
Sepahdari AR, Ishiyama G, Vorasubin N, Peng KA, Linetsky M, Ishiyama A (2015) Delayed intravenous contrast-enhanced 3D FLAIR MRI in Meniere’s disease: correlation of quantitative measures of endolymphatic hydrops with hearing. Clin Imaging 39(1):26–31
doi: 10.1016/j.clinimag.2014.09.014
Attyé A, Eliezer M, Medici M, Tropres I, Dumas G, Krainik A, Schmerber S (2018) In vivo imaging of saccular hydrops in humans reflects sensorineural hearing loss rather than Meniere’s disease symptoms. Eur Radiol 28:1–7
doi: 10.1007/s00330-017-5260-7
Eliezer M, Poillon G, Maquet C, Gillibert A, Horion J, Marie JP, Attyé A (2019) Sensorineural hearing loss in patients with vestibular schwannoma correlates with the presence of utricular hydrops as diagnosed on heavily T2-weighted MRI. Diagn Interv Imaging 100(5):259–268
doi: 10.1016/j.diii.2019.01.006
Zhang W, Hui L, Zhang B, Ren L, Zhu J, Wang F, Li S (2020) The correlation between endolymphatic hydrops and clinical features of meniere disease. Laryngoscope 00:1–7
Salt AN, Plontke SK (2010) Endolymphatic hydrops: pathophysiology and experimental models. Otolaryngol Clin North Am 43(5):971–983
doi: 10.1016/j.otc.2010.05.007
Asmar MH, Gaboury L, Saliba I (2018) Ménière’s disease pathophysiology: endolymphatic sac immunohistochemical study of aquaporin-2, V2R vasopressin receptor, NKCC2, and TRPV4. Otolaryngol Head Neck Surg 158(4):721–728
doi: 10.1177/0194599818756829
Silverstein H, Schuknecht HF (1966) Biochemical studies of inner ear fluid in man. Arch Otolaryngol 84:395–402
doi: 10.1001/archotol.1966.00760030397003
Naganawa S, Kawai H, Sone M, Nakashima T, Ikeda M (2011) Endolympathic hydrops in patients with vestibular schwannoma: visualization by non-contrast-enhanced 3D FLAIR. Neuroradiology 53(12):1009–1015
doi: 10.1007/s00234-010-0834-y
Lee IH, Kim HJ, Chung WH, Kim E, Moon JW, Kim ST, Byun HS (2010) Signal intensity change of the labyrinth in patients with surgically confirmed or radiologically diagnosed vestibular schwannoma on isotropic 3D fluid-attenuated inversion recovery MR imaging at 3 T. Eur Radiol 20(4):949–957
doi: 10.1007/s00330-009-1626-9
Venkatasamy A, Le Foll D, Karol A, Lhermitte B, Charpiot A, Debry C, Veillon F (2017) Differentiation of vestibular schwannomas from meningiomas of the internal auditory canal using perilymphatic signal evaluation on T2-weighted gradient-echo fast imaging employing steady state acquisition at 3T. Eur Radiol Exp 1(1):8
doi: 10.1186/s41747-017-0012-7
Dixon JK, Loney E (2016) Hearing loss in vestibular schwannoma: size isn't everything. Clin Radiol 71:S4
doi: 10.1016/j.crad.2016.06.033
Asthagiri AR, Vasquez RA, Butman JA, Wu T, Morgan K, Brewer CC, Lonser RR (2012) Mechanisms of hearing loss in neurofibromatosis type 2. PLoS ONE 7(9):e46132
doi: 10.1371/journal.pone.0046132
Dilwali S, Lysaght A, Roberts D, Barker FG, McKenna MJ, Stankovic KM (2013) Sporadic vestibular schwannomas associated with good hearing secrete higher levels of fibroblast growth factor 2 than those associated with poor hearing irrespective of tumor size. Otol Neurotol 34(4):748–754
doi: 10.1097/MAO.0b013e31828048ec
Thomsen J, Saxtrup O, Tos M (1982) Quantitated determination of proteins in perilymph in patients with acoustic neuromas. ORL J Otorhinolaryngol Relat Spec 44(2):61–65
doi: 10.1159/000275574
O’Connor AF, France MW, Morrison AW (1981) Perilymph total protein levels associated with cerebellopontine angle lesions. Am J Otol 2(3):193–195
pubmed: 6974501

Auteurs

Aïna Venkatasamy (A)

Service de Radiologie 1, Hôpitaux Universitaires de Strasbourg, 1 avenue Molière, 67200, Strasbourg, France. aina.venkatasamy@chru-strasbourg.fr.
Inserm IRFAC UMR_S1113, Laboratory Stress Response and Innovative Therapies "Streinth", Université de Strasbourg, Strasbourg, France. aina.venkatasamy@chru-strasbourg.fr.

Pauline Bretz (P)

Service de Radiologie 1, Hôpitaux Universitaires de Strasbourg, 1 avenue Molière, 67200, Strasbourg, France.

Anne Karol (A)

Service de Radiologie 1, Hôpitaux Universitaires de Strasbourg, 1 avenue Molière, 67200, Strasbourg, France.

Aurélie Karch-Georges (A)

Service de Radiologie 1, Hôpitaux Universitaires de Strasbourg, 1 avenue Molière, 67200, Strasbourg, France.

Anne Charpiot (A)

Service de Chirurgie ORL, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Francis Veillon (F)

Service de Radiologie 1, Hôpitaux Universitaires de Strasbourg, 1 avenue Molière, 67200, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH